StockSwissALC.SW

Alcon Inc

CHF 54.02

+0.24 (+0.45%)today

Valuation & earnings

P/E ratio: 50.02
Forward P/E: 15.04
EPS (ttm): CHF 1.08
Forward EPS: CHF 3.59
Price/book: 1.47
PEG ratio: 1.16
Dividend yield: 0.52%
Payout ratio: 27.03%

Financials (ttm)

Revenue (ttm): 10.9B
Revenue growth: 8.7%
Profit margin: 5.92%
Return on equity: 2.94%
Total cash: 1.5B
Total debt: 5.3B

Earnings (EPS)

Quarter	Estimate	Actual	Surprise
Sep 30, 2025	0.85	0.79	-7.06%
Dec 31, 2025	0.87	0.78	-10.34%
Mar 31, 2026	0.82	0.85	+4.06%
Jun 30, 2026	0.76	0.84	+11.21%

Next earnings date: Nov 10, 2026

Analyst view

Consensus ratingBuy26 analysts

Strong buy 4Buy 17Hold 4Strong sell 1

12-month price targetsImplied upside: +39.42%

48.86

75.31

86.82

LowCurrent priceHigh

Dividends

Dividend yield: 0.52%
Dividend (annual): CHF 0.28
Ex-dividend date: May 5, 2026

Recent payments

May 4, 2026 · CHF 0.28May 12, 2025 · CHF 0.28May 13, 2024 · CHF 0.24May 9, 2023 · CHF 0.21May 2, 2022 · CHF 0.20

Key stats

Previous close: CHF 53.78
Day range: 53.46 – 54.18
52-week range: 47.8 – 68.34
Volume: 683.2K
Avg. volume: 1.3M
Market cap: 26.1B
Beta: 0.7
52-week change: -10.1%
Currency: CHF

Profile

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY(English)

Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 25,000
Headquarters: Geneva, Switzerland

Visit website

Market data provided by Yahoo Finance, may be delayed. For informational purposes only — not investment advice.